Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 96Rectal Neoplasms 42Colonic Neoplasms 38Stomach Neoplasms 31Pancreatic Neoplasms 31Neoplasm Metastasis 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Neoplasms 21Esophageal Neoplasms 19Burkitt Lymphoma 15Adenocarcinoma Of Esophagus 14Lymphoma 13Leukemia 8Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Osteosarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Biphenotypic, Acute 4Gastrointestinal Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Hepatocellular 4Liver Neoplasms 3Intestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Bile Duct Neoplasms 3Somatostatinoma 2

Interventions

pembrolizumab 37Paclitaxel 36Carboplatin 31Cyclophosphamide 22Albumin-Bound Paclitaxel 20atezolizumab 16130-nm albumin-bound paclitaxel 16Taxes 15Doxorubicin 15Cisplatin 13Capecitabine 13Nivolumab 10Docetaxel 8olaparib 7Gemcitabine 6Everolimus 6talazoparib 5durvalumab 5Magnetic Resonance Spectroscopy 5Biopsy 5Bevacizumab 5veliparib 4spartalizumab 4sacituzumab govitecan 4pegfilgrastim 4liposomal doxorubicin 4eribulin 4Specimen Handling 4Immunoglobulin G 4trilaciclib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Triple Negative Breast Neoplasms × Leucovorin × Clear all
NCT03387085 2024-08-09

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

ImmunityBio, Inc.

Phase 1/2 Terminated
9 enrolled 18 charts
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡